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Abstract cAMP response element binding protein-2 (CREB-2)
is a basic leucine zipper (bZIP) factor that was originally
described as a repressor of CRE-dependent transcription but that
can also act as a transcriptional activator. Moreover, CREB-2 is
able to function in association with the viral Tax protein as an
activator of the human T-cell leukemia virus type I (HTLV-I)
promoter. Here we show that CREB-2 is able to interact with C/
EBP-homologous protein (CHOP), a bZIP transcription factor
known to inhibit CAAT/enhancer-dependent transcription. Co-
transfection of CHOP with CREB-2 results in decreased
activation driven by the cellular CRE motif or the HTLV-I
proximal Tax-responsive element, confirming that CREB-2 and
CHOP can interact with each other in vivo. ß 2001 Published
by Elsevier Science B.V. on behalf of the Federation of Euro-
pean Biochemical Societies.
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1. Introduction
The basic leucine zipper (bZIP) transcription factors play
an important role in regulating the expression of various
genes. This group of transcription factors contain a leucine
zipper as a common motif required for protein dimerization.
Homo- or heterodimerization is a prerequisite for speci¢c
DNA binding. DNA binding speci¢city is determined by a
DNA interaction surface being provided by a basic region
of about 20 amino acids that precedes the leucine zipper.
The di¡erent members were originally classi¢ed into families
by their ability to bind speci¢c sites. For instance, the mem-
bers of the activating transcription factor/cAMP response el-
ement binding protein (ATF/CREB) family speci¢cally bind
to the palindromic cAMP response element (CRE) TGACGT-
CA. Thus, CREB-2 has been isolated from a Jurkat T-cell
cDNA library by using as a probe the human T-cell receptor
K enhancer CRE motif [1] or the related CRE site
TGACGTCT corresponding to the distal human T-cell leuke-
mia virus type I (HTLV-I) Tax-responsive element (TxRE) [2].
CREB-2, also called ATF-4 or TAXREB-67 [2,3], together
with the mouse mATF-4, mTR67, C/ATF, and the Aplysia
ApCREB-2, represents a subfamily of the ATF/CREB pro-
teins [4^6]. Although CREB-2 was originally described as a
repressor of CRE-dependent transcription [1,7,8], it contains a
constitutive activation domain of transcription [6,9,10] and
can directly interact with the transcriptional coactivator
CREB binding protein [6,10]. We and others have demon-
strated that CREB-2 cooperates with the viral Tax protein
to enhance the transcription of the HTLV-I promoter
[11,12], Tax enhancing the binding of CREB-2 to the three
TxREs [10] present in the HTLV-I long terminal repeat
(LTR).
CREB-2 is known to form heterodimers in vitro with other
bZIP transcription factors such as members of the activator
protein-1 (AP-1) [13,14] and CCAAT/enhancer-binding pro-
tein (C/EBP) [4,15] families. To characterize other bZIP fac-
tors that can interact with CREB-2, we performed a Saccha-
romyces cerevisiae two-hybrid approach using a cDNA library
previously synthesized by ourselves [12] from mRNA of the
MT2 cell line, a T-cell line infected by HTLV-I. By this ap-
proach, we isolated three independent cDNAs encoding the C/
EBP-homologous protein (CHOP) that is also known as
GADD153 [16,17]. In this study, we demonstrate that
CREB-2 directly interacts with CHOP, CREB-2 and CHOP
associating via their bZIP domains. In addition, we show by
cotransfection assays in CEM cells that CHOP is able to
down-regulate CREB-2-dependent transcription con¢rming
the interaction of CHOP with CREB-2 in vivo.
2. Materials and methods
2.1. Plasmids
For interaction experiments with yeast, cDNA encoding the CREB-
2 bZIP domain [10] was ligated as an EcoRI-SalI fragment into the
LEXA DNA binding domain of the pBTM116 vector [18] to give
pLEXA-CREB-2 bZIP. The wild-type CHOP and the truncated mu-
tant were cloned in frame with the GAL4 activation domain of
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pGAD424 (Clontech). CHOP cDNA was generated by PCR ampli¢-
cation on the vector pCMV-Neo-CHOP, digested by EcoRI and sub-
cloned into pGAD424 to give pGAD-CHOP. The CHOP deletion
mutant without the leucine zipper (pGAD-CHOP vZIP) was obtained
by digesting pGAD-CHOP by SmaI and the resulted digest was re-
ligated. The eukaryotic vectors pCI-CREB-2, pSG-Tax, pBg312HIV-
1Lai-Tat, and pCMV-Neo-CHOP expressing CREB-2, Tax, Tat, and
CHOP, respectively, have been described elsewhere [10,18,19]. The
plasmid pCMV-Neo-CHOP vZIP, which contains the entire coding
sequence of CHOP except for its ZIP domain, was constructed by
digesting pCMV-Neo-CHOP with NheI; the resulting digest was
treated with Klenow and religated as blunt ends. For the assays
with the GAL4 binding site promoter-reporter plasmid, the vector
containing the CREB-2 C-terminal domain (amino acids 263^351)
fused in frame with the DNA binding domain of GAL4 (cloned
into pBIND vector, Promega) has already been described [10].
2.2. Screening for proteins that interact with the CREB-2 bZIP domain
MT2 cDNA fused to the GAL4 activation domain of the pGAD10
vector [12] was screened using the CREB-2 bZIP domain as bait fused
to the LEXA DNA binding domain of the pBTM116 vector. The two-
hybrid screen was performed as already described [12]. Brie£y,
pLEXA-CREB-2 bZIP and the fusion cDNA library were cointro-
duced into the L40 S. cerevisiae strain by the lithium acetate method
[20]. The L40 yeast strain possesses the His synthase gene (His3) and
the lacZ gene under the control of LEXA binding sites. From approx-
imately 9U106 clones screened, we selected robust colonies growing
on agar medium lacking Trp, Leu and His, for those that contained
both types of plasmids (Leu and Trp) and that also expressed
interacting hybrid proteins (His). Selected transformants were as-
sayed for the expression of lacZ by the L-galactosidase ¢lter assay
as described in the Clontech protocol. Plasmid DNA of the clones
that were strongly positive for L-galactosidase activity was extracted,
analyzed by digestion with restriction enzymes and sequenced. The L-
galactosidase assay with O-nitrophenyl-L-D-galactoside (ONPG) as
substrate was carried out on three independent colonies per transfor-
mation as described in the Clontech protocol. The L-galactosidase
activity was calculated in Miller units [21].
2.3. Glutathione S-transferase (GST) pull-down assay
CREB-2 cDNA cloned into pCI-neo [12] was transcribed and trans-
lated in the presence of [35S]methionine using the TNT T7 coupled
reticulocyte lysate system of Promega, and incubated at 4‡C with
equal amounts of GST-CHOP or GST immobilized on glutathione
Sepharose beads (Bulk GST puri¢cation module of Pharmacia) in a
bu¡er containing 50 mM Tris^HCl, pH 7.4, 1 mM EDTA, 250 mM
NaCl, 0.1% Nonidet P-40. After 2 h incubation, the beads were
washed ¢ve times with incubation bu¡er and the bound proteins
were analyzed by SDS^PAGE followed by autoradiography.
2.4. Confocal microscopy analysis
COS7 cells were transfected using the calcium phosphate-mediated
transfection method with 10 Wg of the plasmid pEGFP-CREB-2 ex-
pressing a GFP (green £uorescent protein)-CREB-2 fusion protein
and 10 Wg of the CHOP expression vector pCMV-Neo-CHOP. Cells
were cultivated on glass slides and then analyzed by £uorescence 24 h
after transfection as already described [12,18]. CHOP was detected
using anti-CHOP mAb (Santa Cruz Biotechnology) and goat anti-
mouse IgG antibody coupled to rhodamine (Pierce). Analysis of the
green, red, and yellow £uorescence was performed with a Bio-Rad
MRC 1024 confocal microscope.
2.5. Transfections and luciferase assays
The lymphoblastoid CEM cell line was obtained from the American
Type Culture Collection (Bethesda, MD). Cells were cultured in
RPMI 1640 medium supplemented with 1% penicillin^streptomycin
antibiotic mixture, 1% glutamax (Life Technologies, Eragny, France)
and 10% FCS (Life Technologies), to a density of 5U105 cells/ml in a
5% CO2 atmosphere. CEM cells were transiently cotransfected ac-
cording to the previously published procedure [22]. 5 Wg of a L-galac-
tosidase-containing plasmid (pACL1) was included in each transfec-
tion to check the transfection e⁄ciency. The total amount of DNA in
each series of transfections was equal, the balance being made up with
empty vectors. Cell extracts equalized for protein content were used
for luciferase and L-galactosidase assays [22].
3. Results and discussion
To identify proteins interacting with CREB-2 by the two-
hybrid approach in S. cerevisiae, we ¢rst cloned the complete
coding sequence of CREB-2 in frame with the cDNA encod-
ing the LEXA DNA binding domain. However, when this
fusion protein was expressed in S. cerevisiae, reporter gene
expression was activated as already described in T cells
[6,12]. For this reason, the activation domain of CREB-2
was removed and the cDNA expression library was screened
using the CREB-2 bZIP (amino acids 263^351) domain as a
bait. Several positive clones were found to correspond to the
transcriptional factor CHOP (Fig. 1A).
CHOP is a small bZIP factor that is expressed in response
to metabolic stresses. CHOP dimerizes with members of the
C/EBP family [17,19,23] and the resulting heterodimers are no
Fig. 1. CREB-2 interacts with CHOP in the yeast two-hybrid sys-
tem. A: Clones isolated corresponding to CHOP. The MT2 cDNA
library was screened using the bZIP domain of CREB-2 as a bait
fused to the LEXA DNA binding domain. Three di¡erent cDNAs
encoding CHOP were obtained. The numbers under the diagrams
are CHOP amino acid positions. The bZIP domain is indicated by
a striped box. B: Analysis of the interaction between CREB-2 bZIP
and CHOP in S. cerevisiae. The L40 yeast cells were transformed
with an expression vector containing the entire coding sequence of
the CHOP cDNA clone fused to the GAL4 activation domain
(pGAD-CHOP) together with plasmids expressing either the LEXA
DNA binding domain alone (pLEXA), or fused to CREB-2 bZIP
(pLEXA-CREB-2 bZIP), or fused to lamin (pLEXA-lamin).
pLEXA-CREB-2 bZIP was also cotransformed with a plasmid ex-
pressing either the GAL4 activation domain alone (pGAD), or
fused to a truncated form of CHOP without leucine zipper (pGAD-
CHOP vZIP). The L-galactosidase assay with ONPG as substrate
was carried out on three independent colonies per transformation.
The mean values expressed in Miller units are shown.
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longer capable of binding to CAAT/enhancer consensus sites
[17]. However, the CHOP-C/EBP heterodimer can bind to a
speci¢c CHOP-responsive element distinct from the C/EBP
motif [24,25]. CHOP, when bound to the promoter, is able
to activate transcription, phosphorylation of CHOP by p38
mitogen-activated protein kinase enhancing its transcriptional
activity [26]. CHOP is also able to form heterodimers with
other bZIP family members such as AP-1 proteins and
ATF-3 [27,28] but has not been yet demonstrated to interact
with CREB-2.
All the isolated cDNAs of CHOP encoded the leucine zip-
per suggesting that this domain is required for the interaction
between CREB-2 and CHOP. To test this possibility, we pro-
duced a truncated mutant of CHOP without leucine zipper,
which was analyzed by using the yeast two-hybrid system as
already described [10]. For this analysis, the full-length prod-
uct of CHOP and its mutated form were fused at their amino-
termini to the activation domain of the yeast transcription
factor GAL4 (pGAD-CHOP and pGAD-CHOP vZIP) and
were tested in S. cerevisiae in the presence of the CREB-2
bZIP domain fused at its amino-terminus to the LEXA
DNA binding domain (pLEXA-CREB-2 bZIP). As shown
in Fig. 1B, CHOP was no longer able to interact with
CREB-2 when its leucine zipper was deleted. Moreover, to
be sure of the speci¢city of the test, CHOP was also tested
in the presence of an unrelated protein (pLEXA-lamin). In
these conditions, no signi¢cant L-galactosidase activity was
detected (Fig. 1B).
It could not be excluded on the basis of the results obtained
in yeast that the interaction between CHOP and CREB-2 was
not direct but rather required yeast components. To eliminate
this possibility, we analyzed the interaction between CHOP
and CREB-2 in vitro using recombinant proteins. A fusion
protein of CHOP with GST was produced in Escherichia coli
and the binding to [35S]methionine-labeled CREB-2 produced
in rabbit reticulocyte lysate was analyzed. As shown in Fig. 2,
[35S]CREB-2 bound to GST-CHOP but not to GST alone.
This result demonstrates that CREB-2 interacts with CHOP
also in vitro.
To con¢rm the in vivo relevance of the interaction between
CREB-2 and CHOP, we ¢rst studied the localization of both
proteins inside cells. COS cells were cotransfected with the
plasmid pEGFP-CREB-2 expressing a GFP-CREB-2 fusion
protein and the CHOP expression vector pCMV-Neo-
CHOP. Cells were examined under the confocal microscope
(Fig. 3A). Colocalization of CREB-2 and CHOP in the nu-
cleus was visualized in yellow color (Fig. 3A, c) corresponding
to the merging of the green £uorescence of the GFP-CREB-2
fusion protein (Fig. 3A, a) and the red staining of CHOP
detected by indirect immuno£uorescence (rhodamine) (Fig.
3A, b). This result shows that both proteins localized in the
nucleus and raises the possibility that CREB-2 might interact
with CHOP in the nucleus. To con¢rm this possibility, we
used a transient transfection assay performed in CEM cells
where the bZIP domain of CREB-2 was directly bound to the
promoter of the reporter gene. For this assay, we used a
GAL4-CREB-2 bZIP fusion protein in which the GAL4
DNA binding domain was linked in frame to the C-terminal
domain of CREB-2 encompassing the amino acid residues
from position 263 to 351. This CREB-2 region has lost the
activation domain [10] but still contains the bZIP domain
involved in the interaction with CHOP. GAL4-CREB-2
bZIP was assayed using the reporter plasmid pG5luc encoding
luciferase under the control of ¢ve GAL4 binding sites up-
stream of a minimal TATA box. As expected, after cotrans-
fection with pG5luc, GAL4-CREB-2 bZIP was unable to
stimulate the luciferase expression (Fig. 3B) since no activa-
tion domain was present. On the other hand, if the GAL4-
CREB-2 bZIP was able to interact with CHOP in vivo, the
luciferase expression should be stimulated in the presence of
CHOP, GAL4-CREB-2 bZIP supplementing the absence of
the CREB-2 activation domain by recruiting CHOP. Indeed,
when CHOP was added, luciferase expression was stimulated
about 135-fold (Fig. 3B). When the same experiment was
carried out with CHOP in the presence of the GAL4 DNA
binding domain without the CREB-2 bZIP or with CHOP
vZIP in the presence of GAL4-CREB-2 bZIP, no stimulation
was detected con¢rming that CHOP enhanced luciferase ex-
pression by interacting with the CREB-2 bZIP domain bound
to the GAL4 binding sites. Taken together, our results dem-
onstrate that CREB-2 and CHOP interact in vivo.
CHOP has been demonstrated to act as a negative regulator
of C/EBP proteins by forming heterodimers that are unable to
bind to CAAT/enhancer consensus sites [17]. Similarly, CHOP
negatively modulates the activity of ATF-3, which like CREB-
2 is a member of the ATF/CREB family. Indeed, CHOP/
ATF-3 heterodimers are unable to bind to the CRE motif
[27]. This result predicts that if CHOP interacted with
CREB-2 in vivo, CHOP should also block CREB-2 transcrip-
tional activity on promoters containing CRE. To test this
possibility, CEM cells were cotransfected with a luciferase
reporter construct carrying a synthetic promoter containing
three tandemly repeated copies of the cellular palindromic
CRE site, the CREB-2 expression vector pCI-CREB-2, and
increasing amounts of pCMV-Neo-CHOP. Expression of
CREB-2 caused a four-fold increase in CRE-dependent tran-
Fig. 2. Binding of CREB-2 to CHOP in vitro. GST-CHOP fusion
protein was puri¢ed from E. coli. In vitro translated CREB-2 in the
presence of [35S]methionine (lane 1) was incubated with equal
amounts of GST (lane 2) or GST-CHOP fusion protein (lane 3) im-
mobilized on glutathione Sepharose beads. After incubation, the
bound proteins were analyzed by SDS^PAGE followed by autora-
diography.
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scription (Fig. 4A). This result was in accord with previous
studies [4,10]. On the other hand, expression of CHOP sup-
pressed luciferase transcription back to baseline levels (Fig.
4A). In addition, we also analyzed whether CHOP could
down-regulate the HTLV-I transcription in a cotransfection
assay. Indeed, CREB-2 is able to transactivate the HTLV-I
promoter [11,12] when its binding to the TxRE motifs is en-
hanced by the viral Tax protein [10]. CEM cells were cotrans-
fected with a luciferase reporter construct carrying a synthetic
promoter containing three tandem copies of the promoter-
proximal TxRE, the Tax expression vector pSG-Tax, pCI-
CREB-2, and increasing amounts of pCMV-Neo-CHOP.
Fig. 4B shows that the reporter was e¡ectively stimulated
110-fold with CREB-2 and Tax, but this stimulation was in-
hibited in the presence of CHOP (only a 30-fold stimulation).
As shown in Fig. 4A with the cellular palindromic CRE site,
when the experiment was performed with CHOP vZIP, such a
repression was not observed (Fig. 4B). In order to be sure that
this inhibition was not due to a non-speci¢c e¡ect of CHOP
on cellular transcription, CHOP was also tested in CEM cells
with the human immunode¢ciency virus type 1 (HIV-1) pro-
moter in the presence of the HIV-1 activator Tat. Under these
conditions, CHOP did not down-regulate the HIV-1 transcrip-
tion stimulated by Tat (Fig. 4C), con¢rming that the decrease
in transactivation by CHOP from the cellular CRE in the
presence of CREB-2 and from the HTLV-I TxRE in the pres-
ence of Tax and CREB-2 was speci¢c. Lastly, we also checked
that CHOP was unable to interact directly with Tax (data not
shown). In conclusion, as predicted, CHOP negatively modu-
lates CREB-2 activity on a promoter containing CRE or re-
lated motifs. However, we do not rule out the possibility that
the CHOP-CREB-2 heterodimer can bind to DNA sequences
Fig. 3. Binding of CREB-2 to CHOP in vivo. A: Analysis by confocal microscopy of the colocalization of CREB-2 and CHOP in vivo. COS
cells were cotransfected with pEGFP-CREB-2 and pCMV-Neo-CHOP. Analysis of the green (a), red (b) and merged (c) £uorescence was per-
formed with confocal microscopy. CHOP was detected using anti-CHOP monoclonal antibody and goat anti-mouse IgG antibody coupled to
rhodamine. B: CREB-2 and CHOP interact in vivo. CEM cells were cotransfected with 2 Wg of the luciferase reporter vector pG5luc, 2.5 Wg of
pBIND expressing the GAL4 DNA binding domain fused (GAL4 CREB-2 bZIP) or not (GAL4 DNA-BD) to the CREB-2 bZIP domain, and
increasing amounts of pCMV-Neo-CHOP (0.1 and 0.5 Wg) or pCMV-Neo-CHOP vZIP (0.5 Wg). The total amount of DNA in each series of
transfections was equal, the balance being made up with empty plasmids. The luciferase values were normalized for L-galactosidase activity and
expressed as fold increase relative to that of cells transfected with pG5luc, pBIND and pCMV-Neo. Values represent the mean þ S.D. (n = 3).
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unrelated to the CRE motif, this interaction possibly resulting
in activation of transcription.
In this paper, we demonstrate that CREB-2 can interact
with another bZIP protein, the transcriptional factor CHOP,
although the two proteins are distinguished by their consensus
recognition sites. In addition, we ¢nd that CREB-2 in the
presence of CHOP is no longer able to activate the transcrip-
tion from CRE or related sites such as TxREs. From these
results, it is tempting to postulate that balance between the
production of CHOP and CREB-2 could be involved in the
regulation of HTLV-I transcription in infected T cells. In the
same way, CHOP could control its own expression since
CHOP promoter activity is controlled by CREB-2 through a
C/EBP-ATF composite site [29]. However, all these hypoth-
eses remain speculative for the moment and should be inves-
tigated further to clearly demonstrate the physiological impor-
tance of the CREB-2/CHOP heterodimer in the cell.
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